| Mrs Sharon Henrietta Barrett, MD | |
|
8 East Main Street, Suite 101, Clinton, CT 06413-2058 | |
| (860) 669-6156 | |
| (860) 664-0285 |
| Full Name | Mrs Sharon Henrietta Barrett |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Location | 8 East Main Street, Clinton, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467466284 | NPI | - | NPPES |
| 001264639 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | CT026463 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Sharon Henrietta Barrett, MD 8 East Main Street, Suite 101, Clinton, CT 06413-2058 Ph: (860) 669-6156 | Mrs Sharon Henrietta Barrett, MD 8 East Main Street, Suite 101, Clinton, CT 06413-2058 Ph: (860) 669-6156 |
News Archive
Computer engineers at Washington University in St. Louis are bringing the minimalist approach to medical care and computing by coupling USB-based ultrasound probe technology with a smartphone, enabling a compact, mobile computational platform and a medical imaging device that fits in the palm of a hand.
Researchers from St. Jude Children's Research Hospital and the Pediatric Brain Tumor Consortium (PBTC) presented at the American Society of Clinical Oncology the findings of a pediatric brain tumor study using an experimental drug that targets the underlying genetic makeup of the tumor. The research focused on a new way to attack the tumors by blocking the Hedgehog pathway that is linked to approximately 20 percent of medulloblastomas.
Researchers at Karolinska Institutet and the Sahlgrenska Academy in Sweden might be one step closer to finding an effective drug for alcohol dependence. In two separate studies, they show that the so-called dopamine stabilizer OSU6162 can reduce the craving for alcohol in alcohol dependent people and normalises the level of dopamine in the brain reward system of rats that have consumed alcohol over a long period of time.
Agena Bioscience, Inc., which recently acquired the Bioscience business of Sequenom, Inc., today announced expansion of the UltraSEEK™ technology, the first ultrasensitive somatic mutation detection technology for high-throughput and definitive interrogation of rare mutations that occur at less than 1% abundance in matched tissue, circulating plasma, and tumor samples.
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced interim results of CLL-009, a study evaluating three starting doses of REVLIMID (lenalidomide), followed by step-wise dose escalation as tolerated in patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
› Verified 4 days ago
Mrs. Carolyn B Carroll, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8 East Main Street, Suite 101, Clinton, CT 06413 Phone: 860-669-6156 Fax: 860-664-0285 | |
Mrs. Ellen A Markstein, MD Dermatology Medicare: Medicare Enrolled Practice Location: 8 East Main Street, Suite 101, Clinton, CT 06413 Phone: 860-669-6156 Fax: 860-664-0285 |